107 related articles for article (PubMed ID: 30244946)
1. Cytoplasmic Pin1 expression is correlated with poor prognosis in colorectal cancer.
Pyo JS; Son BK; Oh IH
Pathol Res Pract; 2018 Nov; 214(11):1848-1853. PubMed ID: 30244946
[TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis.
Chen X; Liu X; Deng B; Martinka M; Zhou Y; Lan X; Cheng Y
Sci Rep; 2018 Nov; 8(1):16867. PubMed ID: 30442923
[TBL] [Abstract][Full Text] [Related]
3. TPL2 expression is correlated with distant metastasis and poor prognosis in colorectal cancer.
Pyo JS; Park MJ; Kim CN
Hum Pathol; 2018 Sep; 79():50-56. PubMed ID: 29763718
[TBL] [Abstract][Full Text] [Related]
4. BRG1 is correlated with poor prognosis in colorectal cancer.
Pyo JS; Son BK; Oh D; Kim EK
Hum Pathol; 2018 Mar; 73():66-73. PubMed ID: 29288038
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathological significance of micropapillary pattern in colorectal cancers.
Pyo JS; Park MJ; Kang DW
Hum Pathol; 2018 Jul; 77():159-165. PubMed ID: 29634975
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological significance and prognostic implication of nuclear factor-κB activation in colorectal cancer.
Pyo JS; Kim EK
Pathol Res Pract; 2019 Aug; 215(8):152469. PubMed ID: 31201065
[TBL] [Abstract][Full Text] [Related]
7. The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.
Ayala G; Wang D; Wulf G; Frolov A; Li R; Sowadski J; Wheeler TM; Lu KP; Bao L
Cancer Res; 2003 Oct; 63(19):6244-51. PubMed ID: 14559810
[TBL] [Abstract][Full Text] [Related]
8. Loss of Hes1 expression is associated with poor prognosis in colorectal adenocarcinoma.
Ahadi M; Andrici J; Sioson L; Sheen A; Clarkson A; Gill AJ
Hum Pathol; 2016 Nov; 57():91-97. PubMed ID: 27476040
[TBL] [Abstract][Full Text] [Related]
9. Expression of clusterin in colorectal carcinoma in relation to clinicopathological criteria.
Gomaa W; Al-Ahwal M; Al-Maghrabi H; Buhmeida A; Al-Qahtani M; Al-Maghrabi B; Al-Maghrabi J
Malays J Pathol; 2017 Dec; 39(3):243-250. PubMed ID: 29279586
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.
Jia X; Shanmugam C; Paluri RK; Jhala NC; Behring MP; Katkoori VR; Sugandha SP; Bae S; Samuel T; Manne U
Oncotarget; 2017 Mar; 8(12):20198-20212. PubMed ID: 28423626
[TBL] [Abstract][Full Text] [Related]
11. Nuclear maspin expression correlates with the CpG island methylator phenotype and tumor aggressiveness in colorectal cancer.
Kim JH; Cho NY; Bae JM; Kim KJ; Rhee YY; Lee HS; Kang GH
Int J Clin Exp Pathol; 2015; 8(2):1920-8. PubMed ID: 25973084
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Prognosis in Colorectal Cancers.
Lee SH; Yoo HJ; Rim DE; Cui Y; Lee A; Jung ES; Oh ST; Kim JG; Kwon OJ; Kim SY; Jeong SW
Int J Med Sci; 2017; 14(6):515-522. PubMed ID: 28638266
[No Abstract] [Full Text] [Related]
13. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
[TBL] [Abstract][Full Text] [Related]
14. CYP24A1 is a potential biomarker for the progression and prognosis of human colorectal cancer.
Sun H; Wang C; Hao M; Sun R; Wang Y; Liu T; Cong X; Liu Y
Hum Pathol; 2016 Apr; 50():101-8. PubMed ID: 26997443
[TBL] [Abstract][Full Text] [Related]
15. Pin1 overexpression in colorectal cancer and its correlation with aberrant beta-catenin expression.
Kim CJ; Cho YG; Park YG; Nam SW; Kim SY; Lee SH; Yoo NJ; Lee JY; Park WS
World J Gastroenterol; 2005 Aug; 11(32):5006-9. PubMed ID: 16124054
[TBL] [Abstract][Full Text] [Related]
16. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
[TBL] [Abstract][Full Text] [Related]
17. TGFBI protein high expression predicts poor prognosis in colorectal cancer patients.
Zhu J; Chen X; Liao Z; He C; Hu X
Int J Clin Exp Pathol; 2015; 8(1):702-10. PubMed ID: 25755764
[TBL] [Abstract][Full Text] [Related]
18. Relationship between osteopontin and β-catenin immunohistochemical expression and prognostic parameters of colorectal carcinoma.
Youssef NS; Osman WM
Int J Clin Exp Pathol; 2015; 8(2):1503-14. PubMed ID: 25973035
[TBL] [Abstract][Full Text] [Related]
19. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
20. Altered subcellular localization of suppressin, a novel inhibitor of cell-cycle entry, is an independent prognostic factor in colorectal adenocarcinomas.
Manne U; Gary BD; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
Clin Cancer Res; 2001 Nov; 7(11):3495-503. PubMed ID: 11705868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
